The government is trying to get ahead of rising coronavirus cases that experts fear could snowball into a winter surge with upcoming holiday travel.

With kids back in school, business is picking back up for professional delousers. But how are kids getting head lice if they're physically distancing in the classroom?

The $42 million program, established using CARES Act funding, helped small businesses and nonprofits during the pandemic.

Though the benefits of a third shot are clear, health experts warn the risks for young healthy adults — especially men — should be considered.

Philadelphia health officials urge residents to use caution, and get their COVID-19 boosters, over the winter and the upcoming holidays.

A wide array of apps will display your vaccination status, but privacy experts say they don't all do the same thing.

The initiative comes as the Biden White House has faced growing pressure at home and abroad over inequity in the global vaccine supply.

The program is a collaboration between Philly Counts, Independence Public Media Foundation, and FunTimes Magazine.

The panel advises the Centers for Disease Control and Prevention in setting vaccination recommendations for U.S. doctors and the general public.

A Pennsylvania judge on Tuesday said an order that requires masks inside K-12 schools and child care facilities to contain the coronavirus must expire Dec. 4.

The country is now averaging more than 83,000 cases a day — about a 14% increase compared to a week ago, and 12% more than two weeks ago.

So far, school reopenings in Pennsylvania haven’t triggered a wave of COVID cases or hospitalizations.

The company's filing comes as new infections are rising once again, driven mainly by hot spots in states where colder weather is driving more Americans indoors.

Austria has placed some 2 million unvaccinated people on partial lockdown. Similar restrictions in Berlin have been placed on people who aren't fully vaccinated.

Pfizer said it would grant a license for the pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries.